This inventor holds 1 USPTO granted patent. Top assignee: Synthelabo. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: Howard Stevens: Innovator in Pharmaceutical Composition
Introduction
Howard Stevens is a notable inventor based in Grande-Bretagne, GB. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on sustained-release formulations.
Latest Patents
Stevens holds a patent for a sustained-release pharmaceutical composition of diltiazem. This composition comprises microparticles that contain an active principle, which are coated with a mixture of ethyl cellulose and an acrylic resin. The resin is a polymerizate of acrylic and methacrylic ester, with a molecular weight of at least 100,000. This innovative formulation aims to enhance the delivery and effectiveness of the medication.
Career Highlights
Throughout his career, Howard Stevens has been associated with Synthelabo, a company known for its advancements in pharmaceutical research and development. His work has contributed to the improvement of drug formulations, making them more effective for patients.
Collaborations
Stevens has collaborated with several professionals in his field, including Maryvonne Chariot and Francoise Arnold. These collaborations have fostered a productive environment for innovation and development in pharmaceutical sciences.
Conclusion
Howard Stevens is a distinguished inventor whose work in sustained-release pharmaceutical compositions has made a significant impact in the industry. His contributions continue to influence the development of effective medication delivery systems.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile